Yuki Masuo M.D.
@yuki-masuo.bsky.social
28 followers
65 following
13 posts
PhD student | Ueno Lab | Kyoto University, Japan | Human immunology | Autoimmune diseases
Posts
Media
Videos
Starter Packs
Yuki Masuo M.D.
@yuki-masuo.bsky.social
· Aug 16
Reposted by Yuki Masuo M.D.
Yuki Masuo M.D.
@yuki-masuo.bsky.social
· May 29
Reposted by Yuki Masuo M.D.
Nature
@nature.com
· Apr 16
Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease - Nature
After transplantation into the brain of patients with Parkinson’s disease, allogeneic dopaminergic progenitors derived from induced pluripotent stem cells survived, produced dopamine and did not form tumours, therefore suggesting safety and potential clinical benefits for Parkinson’s disease.
go.nature.com